3D bioprinting is a technology where bioinks, mixed with living cells, are printed in 3D to construct natural tissue-like three-dimensional structures. Currently, this technology can be used in various research areas, such as tissue engineering and new drug development.
The history of 3D bioprinting – where it all began?
3D bioprinting is evolving rapidly since researchers have innovated and driven the field forward. However, as a technology, 3D printing is not a new invention. The first steps in 3D printing were taken in 1980s, when in 1984 Charles Hull filed a patent for the first commercial 3D printing technology. This has been a symbol of the birth of 3D printing, and it created the base for 3D bioprinting as well.
Bioprinting came into picture in 1988, when Robert J. Klebe used inkjet printer for printing cells. After these first steps, the field has constantly evolved, and new methods and techniques have been discovered. The countless possibilities and opportunities to create something ground-breaking keep intriguing scientists, and thus bioprinting has become a popular technology.